Suppr超能文献

鉴定和表征富含亮氨酸重复激酶 2(LRRK2)的一个共识磷酸化模体。

Identification and characterization of a leucine-rich repeat kinase 2 (LRRK2) consensus phosphorylation motif.

机构信息

Global Biotherapeutic Technologies, Pfizer Incorporated, Cambridge, Massachusetts, United States of America.

出版信息

PLoS One. 2010 Oct 27;5(10):e13672. doi: 10.1371/journal.pone.0013672.

Abstract

Mutations in LRRK2 (leucine-rich repeat kinase 2) have been identified as major genetic determinants of Parkinson's disease (PD). The most prevalent mutation, G2019S, increases LRRK2's kinase activity, therefore understanding the sites and substrates that LRRK2 phosphorylates is critical to understanding its role in disease aetiology. Since the physiological substrates of this kinase are unknown, we set out to reveal potential targets of LRRK2 G2019S by identifying its favored phosphorylation motif. A non-biased screen of an oriented peptide library elucidated F/Y-x-T-x-R/K as the core dependent substrate sequence. Bioinformatic analysis of the consensus phosphorylation motif identified several novel candidate substrates that potentially function in neuronal pathophysiology. Peptides corresponding to the most PD relevant proteins were efficiently phosphorylated by LRRK2 in vitro. Interestingly, the phosphomotif was also identified within LRRK2 itself. Autophosphorylation was detected by mass spectrometry and biochemical means at the only F-x-T-x-R site (Thr 1410) within LRRK2. The relevance of this site was assessed by measuring effects of mutations on autophosphorylation, kinase activity, GTP binding, GTP hydrolysis, and LRRK2 multimerization. These studies indicate that modification of Thr1410 subtly regulates GTP hydrolysis by LRRK2, but with minimal effects on other parameters measured. Together the identification of LRRK2's phosphorylation consensus motif, and the functional consequences of its phosphorylation, provide insights into downstream LRRK2-signaling pathways.

摘要

LRRK2(富含亮氨酸重复激酶 2)突变已被确定为帕金森病(PD)的主要遗传决定因素。最常见的突变 G2019S 增加了 LRRK2 的激酶活性,因此了解 LRRK2 磷酸化的位点和底物对于理解其在疾病发病机制中的作用至关重要。由于该激酶的生理底物未知,我们通过鉴定其偏好的磷酸化模体来揭示 LRRK2 G2019S 的潜在靶标。非定向肽文库的无偏筛选阐明了 F/Y-x-T-x-R/K 是依赖核心的底物序列。共识磷酸化模体的生物信息学分析确定了几个潜在的候选底物,它们可能在神经元病理生理学中发挥作用。与最相关的 PD 蛋白相对应的肽在体外可被 LRRK2 有效磷酸化。有趣的是,磷酸化模体也在 LRRK2 本身中被鉴定出来。通过质谱和生化手段在 LRRK2 中唯一的 F-x-T-x-R 位点(Thr1410)检测到自身磷酸化。通过测量突变对自身磷酸化、激酶活性、GTP 结合、GTP 水解和 LRRK2 多聚化的影响来评估该位点的相关性。这些研究表明,Thr1410 的修饰可微妙地调节 LRRK2 的 GTP 水解,但对所测量的其他参数影响最小。LRRK2 磷酸化共识模体的鉴定及其磷酸化的功能后果共同为 LRRK2 信号通路的下游提供了深入的了解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ca5/2965117/562abbfaa27a/pone.0013672.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验